Publications

DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer

The prognostic effects of somatic mutations in ER-positive breast cancer

Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers

DNA damage repair defects as a new class of endocrine treatment resistance driver

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer

Loss of MutL Disrupts Chk2-dependent Cell Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer

Activating HER2 mutations in HER2 gene amplification negative breast cancer

Connecting genomic alterations to cancer biology with proteomics

ER and PI3K Independently Modulate Endocrine Resistance in ER-Positive Breast Cancer

Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

Genome remodelling in a basal-like breast cancer metastasis and xenograft

New concepts in breast cancer genomics and genetics. Breast cancer research

Whole-genome analysis informs breast cancer response to aromatase inhibition

The genomic landscape of breast cancer as a therapeutic roadmap

For more publications visit:

Research Gate

Google Scholar